[新頭殼newtalk] After the emergence of the new coronavirus in late 2019, it became a global pandemic, and the subsequent multiple mutant virus strains are also difficult to prevent. The Omicron mutant strain, known as the new devil, spreads around the world with extremely strong infectivity. Major vaccine manufacturers are also actively testing the mutant strains and preparing to launch new vaccines. Moderna said on the 1st that it expects a modified vaccine for Omicron and other variants to be available and in large quantities this fall.
Moderna’s medical director, Paul Burton, said preliminary data on the Omicron variant will be available in the second quarter and is confident that a booster vaccine for Omicron and other variants will be available this fall.
Burton also called for people who have not yet received the third dose of the vaccine to be vaccinated as soon as possible. The United States is still in the BA.2 subvariant epidemic, and the vaccine can provide protection and prevent severe disease.
Moderna applied to the U.S. Food and Drug Administration (FDA) on April 28 for an Emergency Use Authorization (EUA) for the COVID-19 vaccine for children under 6 years of age. The FDA is expected to approve the authorization in June.
Burton said that the results of the vaccine test in young children have been very successful, and the actual incidence of adverse reactions is even lower than that of children aged 6 to 12.
Moderna is likely to be the first vaccine approved in the U.S. for children 5 and younger.
Pfizer is also expected to submit data on the vaccine for children under 6 by June.
More new head shell reports
“0+7” is expected to be free from isolation?Vaccine coverage is the key Chen Shizhong: Gradually move towards Europe and the United States
People complain about buying and quickly screening Hou Youyi: On average, he can only buy it in nearly a month
Less than 50% of the children’s vaccines in Beicheng are willing to be vaccinated with Modena on the 5th!Cai Bingkun: Respect parents